New Mouse Research May Lead To Liver Stem Cell Therapy For Chronic Liver Disease In Humans

Wednesday, February 27, 2013

Main Category: Liver Disease / Hepatitis
Also Included In: Stem Cell Research
Article Date: 27 Feb 2013 - 1:00 PST

Current ratings for:
New Mouse Research May Lead To Liver Stem Cell Therapy For Chronic Liver Disease In Humans


Patient / Public: not yet rated
Healthcare Prof: not yet rated

For decades scientists around the world have attempted to regenerate primary liver cells known as hepatocytes because of their numerous biomedical applications, including hepatitis research, drug metabolism and toxicity studies, as well as transplantation for cirrhosis and other chronic liver conditions. But no lab in the world has been successful in identifying and growing liver stem cells in culture -- using any available technique - until now.

In the journal Nature, physician-scientists in the Papé Family Pediatric Research Institute at Oregon Health & Science University Doernbecher Children's Hospital, Portland, Ore., along with investigators at the Hubrecht Institute for Developmental Biology and Stem Cell Research, Utrecht, Netherlands, describe a new method through which they were able to infinitely expand liver stem cells from a mouse in a dish.

"This study raises the hope that the human equivalent of these mouse liver stem cells can be grown in a similar way and efficiently converted into functional liver cells," said Markus Grompe, M.D., study co-author, director of the Papé Family Pediatric Research Institute at OHSU Doernbecher Children's Hospital; and professor of pediatrics, and molecular and medical genetics in the OHSU School of Medicine.

In a previous Nature study, investigators at the Hubrecht Institute, led by Hans Clever, M.D, Ph.D., were the first to identify stem cells in the small intestine and colon by observing the expression of the adult stem cell marker Lgr5 and growth in response to a growth factor called Wnt. They also hypothesized that the unique expression pattern of Lgr5 could mark stem cells in other adult tissues, including the liver, an organ for which stem cell identification remained elusive.

In the current Nature study, Grompe and colleagues in the Papé Family Pediatric Research Institute at OHSU Doernbecher used a modified version of the Clever method and discovered that Wnt-induced Lgr5 expression not only marks stem cell production in the liver, but it also defines a class of stem cells that become active when the liver is damaged.

The scientists were able to grow these liver stem cells exponentially in a dish - an accomplishment never before achieved - and then transplant them in a specially designed mouse model of liver disease, where they continued to grow and show a modest therapeutic effect.

"We were able to massively expand the liver cells and subsequently convert them to hepatocytes at a modest percentage. Going forward, we will enlist other growth factors and conditions to improve that percentage. Liver stem cell therapy for chronic liver disease in humans is coming," said Grompe.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our liver disease / hepatitis section for the latest news on this subject.
The study, "In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration," was funded by National Institutes of Health Grant R0I DK05192.
Investigators who contributed to this research include: Grompe, Craig Dorrell, Annelise Haft, Papé Family Pediatric Research Institute, OHSU Doernbecher Children's Hospital; Clever, Meritxell Huch, Sylvia Boj, Johan van Es, Vivian Li, Mare van de Wetering, Toshiro Sato, Karien Hamer, Nobuo Sasaki, Robert Vries, Hubrecht Institute for Developmental Biology and Stem Cell Research; and Milton Finegold, Texas Children's Hospital Houston.
Oregon Health & Science University
Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Oregon Health & Science University. "New Mouse Research May Lead To Liver Stem Cell Therapy For Chronic Liver Disease In Humans." Medical News Today. MediLexicon, Intl., 27 Feb. 2013. Web.
27 Feb. 2013. <http://www.medicalnewstoday.com/releases/256890.php>


APA
Oregon Health & Science University. (2013, February 27). "New Mouse Research May Lead To Liver Stem Cell Therapy For Chronic Liver Disease In Humans." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/256890.php.

Please note: If no author information is provided, the source is cited instead.



'New Mouse Research May Lead To Liver Stem Cell Therapy For Chronic Liver Disease In Humans'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


27 Feb, 2013


-
Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/P69NzuWpwEs/256890.php
--
Manage subscription | Powered by rssforward.com

Powered by Blogger.